Medicis to Buy Inamed for $2.8 Billion in Cash, Stock

Medicis Pharmaceutical Corp. agreed to buy Inamed Corp., the company seeking to return silicone-gel breast implants to the U.S. market for the first time in more than a decade, for $2.8 billion in stock and cash. Inamed investors will get 1.4205 shares of Medicis, a Scottsdale, Ariz.-based maker of skin treatments, and $30 in cash for each share they own, the companies said in a Business Wire statement today. The deal values Inamed at $75 a share, 13 percent more than its closing price March 18.

Bloomberg (http://www.bloomberg.com/apps/news?pid=10000087&sid=a1pH6ItKtOR4)